Results 31 to 40 of about 16,098 (170)

Borrelia miyamotoi in Human-Biting Ticks, United States, 2013–2019 [PDF]

Emerging Infectious Diseases, 2021
During 2013–2019, Borrelia miyamotoi infection was detected in 19 US states. Infection rate was 0.5%–3.2%; of B. miyamotoi–positive ticks, 59.09% had concurrent infections. B.
Guang Xu, Chu-Yuan Luo, Fumiko Ribbe, Patrick Pearson, Michel Ledizet, Stephen M. Rich   +5 more
doaj   +2 more sources

Identification of immunoreactive linear epitopes of Borrelia miyamotoi.

Ticks and Tick-borne Diseases, 2020
Borrelia miyamotoi is an emerging tick-borne spirochete transmitted by ixodid ticks. Current serologic assays for B. miyamotoi are impacted by genetic similarities to other Borrelia and limited understanding of optimal antigenic targets.
Tagliafierro, Teresa, Lipkin, W Ian, Wormser, Gary P., Tokarz, Rafal, Chauhan, Lokendra, Sameroff, Stephen, Wormser, Gary P, Thakkar, Roshni, Mishra, Nischay, Marques, Adriana, Caciula, Adrian, Thakkar, Riddhi, Lipkin, W. Ian, Delaney, Shannon, Chauhan, Lokendra V   +14 more
core   +3 more sources

Antigenic variation is caused by long plasmid segment conversion in a hard tick-borne relapsing fever Borrelia miyamotoi. [PDF]

PLoS Pathogens
Borrelia miyamotoi is a hard tick-borne spirochete genetically related to relapsing fever Borrelia and the etiological agent of an emerging infectious disease in humans. Like relapsing fever Borrelia, B.
Tomohi Takeuchi, Yasuhiro Gotoh, Tetsuya Hayashi, Hiroki Kawabata, Ai Takano   +4 more
doaj   +2 more sources

Surveillance of Borrelia miyamotoi-carrying ticks and genomic analysis of isolates in Inner Mongolia, China [PDF]

Parasites & Vectors, 2021
Background Borrelia miyamotoi is a newly described relapsing fever spirochete transmitted by ixodid tick species. Little is known about the prevalence of B. miyamotoi infections in humans and ticks in Inner Mongolia, China. Therefore, we investigated the
Gaowa, Wulantuya, Kozue Sato, Dan Liu, Yunhong Cui, Xuhong Yin, Lihua Zhang, Hong Li, Tingfu Wang, Rongxin Liu, Lijing Wu, Saixia Lu, Ting Gao, Zitong Zhang, Minzhi Cao, Guodong Wang, Chunpu Li, Dacheng Yan, Norio Ohashi, Shuji Ando, Hiroki Kawabata   +20 more
doaj   +2 more sources

Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised Person

Emerging Infectious Diseases, 2016
Borrelia miyamotoi is a newly recognized human pathogen in the relapsing fever group of spirochetes. We investigated a case of B. miyamotoi infection of the central nervous system resembling B.
Gabriele Margos, Katharina Boden, Volker Fingerle, Sabine Lobenstein, Beate Hermann   +4 more
core   +4 more sources

BACTERICIDAL EFFECT OF HUMAN SERUM ON BORRELIA MIYAMOTOI, CAUSATIVE AGENT OF IXODES TICK-BORNE BORRELIOSIS [PDF]

Журнал микробиологии, эпидемиологии и иммунобиологии, 2018
Aim. In this paper we investigate the impacts of co-incubation of Borrelia miyamotoi with neutrophils. Materials and methods. Spirochetes B. miyamotoi, strain HT31, were incubated 3 hours at 37°C with neutrophils of healthy donors (5*106 cells/ml) in a 1:
A. E. Platonov, J. .. Koetsveld, N. M. Kolyasnikova, O. A. Stukolova, A. S. Dolgova, M. G. Toporkova, D. S. Sarksyan   +6 more
doaj   +2 more sources

Analysis of variable major protein antigenic variation in the relapsing fever spirochete, Borrelia miyamotoi, in response to polyclonal antibody selection pressure. [PDF]

PLoS ONE, 2023
Borrelia miyamotoi is a tick-transmitted spirochete that is genetically grouped with relapsing fever Borrelia and possesses multiple archived pseudogenes that encode variable major proteins (Vmps). Vmps are divided into two groups based on molecular size;
Robert D Gilmore, Brittany A Armstrong, Kevin S Brandt, Taylor J Van Gundy, Andrias Hojgaard, Job E Lopez, Alexander R Kneubehl   +6 more
doaj   +2 more sources

Vitronectin binding protein, BOM1093, confers serum resistance on Borrelia miyamotoi [PDF]

Scientific Reports, 2021
Borrelia miyamotoi, a member of the tick-borne relapsing fever spirochetes, shows a serum-resistant phenotype in vitro. This ability of B. miyamotoi may contribute to bacterial evasion of the host innate immune system.
Kozue Sato, Yumi Kumagai, Tsuyoshi Sekizuka, Makoto Kuroda, Tetsuya Hayashi, Ai Takano, Gaowa, Kyle R. Taylor, Makoto Ohnishi, Hiroki Kawabata   +9 more
doaj   +2 more sources

Glycerophosphodiester Phosphodiesterase Identified as Non-Reliable Serological Marker for Borrelia miyamotoi Disease [PDF]

Microorganisms, 2020
The relapsing fever group Borrelia miyamotoi is an emerging tick-borne pathogen. Diagnosis of infection is currently mainly based on serological methods detecting antibodies against B. miyamotoi glycerophosphodiester phosphodiesterase (GlpQ).
Michael Reiter, Theresa Stelzer, Anna M. Schötta, Mateusz Markowicz, Michael Leschnik, Anna Harsch, Edda Reiß, Richard E. Kneusel, Hannes Stockinger, Gerold Stanek   +9 more
doaj   +2 more sources

Borrelia miyamotoi Meningoencephalitis in an Immunocompetent Patient. [PDF]

Open Forum Infect Dis, 2022
Abstract Borrelia miyamotoi is an underdiagnosed cause of tick-borne illness in endemic regions and, in rare cases, causes neurological disease in immunocompetent patients. Here, we present a case of serologically confirmed Borrelia miyamotoi meningoencephalitis in an otherwise healthy patient who rapidly improved following initiation of
Gandhi S, Gandhi S, Narasimhan S, Workineh A, Mamula M, Yoon J, Krause PJ, Farhadian SF.   +7 more
europepmc   +3 more sources